InspireMD Inc (STU:II2)

Q4 2025 InspireMD Inc Earnings Call Transcript

Mar 18, 2026 / 12:30 PM GMT

Release Date Price: €1.55 (+4.73%)

Transcript 10-K8-K

Key Points

Positve

InspireMD Inc (NSPR) reported a 62% increase in total revenue for Q4 2025, driven by the launch of Seaguard Prime in the US and increased international market penetration.
The company achieved a significant gross margin improvement, with US sales generating about 70% gross margins due to strong pricing and value.
InspireMD Inc (NSPR) completed over 500 cases and gained approvals in prominent IDNs in the US, establishing Seaguard Prime as a go-to device for many physicians.
The company is advancing its clinical pipeline with multiple programs and studies, including the SeaGuardians 2 trial, which could expand market opportunities.
InspireMD Inc (NSPR) has a strong cash position with $54.2 million in cash and equivalents, providing financial stability for future growth initiatives.

Negative

The company reported a net loss of $11.8 million for Q4 2025, an increase from the $9.2 million loss in the same period of 2024.
Operating expenses increased by $3.4 million to $13.3 million in Q4 2025, primarily due to higher commercial staffing and marketing activities.
The launch of Seaguard Prime in the US is still in a controlled phase, which may limit immediate revenue growth potential.
The company faces risks and uncertainties related to FDA approvals for its new products, which could impact future revenue projections.
InspireMD Inc (NSPR) is still in the process of building its US commercial team, which may affect the speed of market penetration and sales growth.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NSPR.OQ - InspireMD Inc
Q4 2025 InspireMD Inc Earnings Call
Mar 18, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to Inspire MD's 4th quarter and full year 2025 earnings conference call. Currently all participants are on listen-only mode. We will facilitate a question-and-answer session towards the end of today's call. This call is being recorded for replay purposes. I would now like to turn the call over to Web Campbell from Good Morning Group for introductory disclosures.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you for joining us for the InspireMD 4th quarter and full year 2025 conference call. Joining us today from InspireMD are Marvin Slawson, Chief Executive

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.